Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals

(2016)   JOURNAL OF HYPERTENSION

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

(2015)   Oncotarget

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

(2011) Patricia A. Ganz et al.   BREAST CANCER RESEARCH AND TREATMENT

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study

(2011) Sunil M. Shah et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins

(2011) Young Kwang Chae et al.   CANCER INVESTIGATION

Use of Angiotensin Receptor Blockers and the Risk of Cancer

(2011) Björn Pasternak et al.   CIRCULATION

Expanding Our Therapeutic Options: Beta Blockers for Breast Cancer?

(2011) Patricia A. Ganz et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

(2011) Thomas I. Barron et al.   JOURNAL OF CLINICAL ONCOLOGY

Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study

(2011) Chia-Hsuin Chang et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

(2011) Amal Melhem-Bertrandt et al.   JOURNAL OF CLINICAL ONCOLOGY

Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study

(2011) T. P. Ahern et al.   JNCI-Journal of the National Cancer Institute

Using β-blockers to inhibit breast cancer progression

(2011) Desmond G. Powe et al.   Nature Reviews Clinical Oncology

The Danish National Prescription Registry

(2011) Helle Wallach Kildemoes et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

(2010) E. K. Sloan et al.   CANCER RESEARCH

Aspirin Intake and Survival After Breast Cancer

(2010) Michelle D. Holmes et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Obesity on Prognosis After Early-Stage Breast Cancer

(2010) Marianne Ewertz et al.   JOURNAL OF CLINICAL ONCOLOGY

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

(2010) Ilke Sipahi et al.   LANCET ONCOLOGY

Danish Breast Cancer Cooperative Group – DBCG: History, organization, and status of scientific achievements at 30-year anniversary

(2008) Mogens Blichert-Toft et al.   ACTA ONCOLOGICA

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

(2008) Susanne Møller et al.   ACTA ONCOLOGICA

Prediagnostic Use of Hormone Therapy and Mortality After Breast Cancer

(2008) P. A. Newcomb et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Is norepinephrine an etiological factor in some types of cancer?

(2008) Paul J. Fitzgerald   INTERNATIONAL JOURNAL OF CANCER